Log In
Print
BCIQ
Print
Print this Print this
 

Captisol-Enabled Clopidogrel IV, clopidogrel (MDCO-157)

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionIV formulation of clopidogrel
Molecular Target Purinergic receptor P2Y G protein-coupled 12 (P2RY12) (P2Y12)
Mechanism of ActionPurinergic receptor antagonist
Latest Stage of DevelopmentPhase III
IndicationAcute coronary syndrome
Partner

The Medicines Co.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today